Home » Authors » Mark McCarty

Articles by Mark McCarty

Red Cross boosting IT systems, recruiting to reduce FDA snags

Nov. 30, 2006

By Mark McCarty

Washington roundup: Fetal oximetry data falls short, Nellcor terminates production

Nov. 30, 2006

By Mark McCarty

Fetal oximetry data falls short, Nellcor terminates production

Nov. 28, 2006

By Mark McCarty

Washington roundup: Study: Medicaid limits stunt migration to managed care

Nov. 27, 2006

By Mark McCarty

SPORT trial hints wait-and-treat may be as effective as surgery

Nov. 27, 2006

By Mark McCarty

Speakers argue vs. Medicare pay for hospital infections

Nov. 22, 2006

By Mark McCarty

IOM report drives senate look at FDA post-market surveillance

Nov. 20, 2006

By Mark McCarty

FDA s Gottlieb floats user fee balloon to cover surveillance

Nov. 16, 2006

By Mark McCarty

Consumers are catching on to healthcare dilemmas facing U.S.

Nov. 15, 2006

By Mark McCarty

Those with equity like devices, but regs make investors wary

Nov. 13, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...